Dual-Pathway Gene Therapy Targets Multiple Drivers in Retinal Disease - Poll - MDSpire

Dual-Pathway Gene Therapy Targets Multiple Drivers in Retinal Disease

At ARVO 2026, Ikarovec presented 4 posters showcasing its bicistronic platform that combines neuroprotection and complement modulation.

  • By

  • Katie Binley, PhD

  • May 1, 2026

  • 3 min

Share

Original Source(s)

Dual-Pathway Gene Therapy Targets Multiple Drivers in Retinal Disease

  • by Katie Binley, PhD

  • May 1, 2026

Related Content

Faster, Reliable, Patient-centered: What’s Next for SPECTRALIS<sup>®</sup>

Upcoming SPECTRALIS Software Version brings new speed, workflow flexibility, and diagnostic depth to multimodal retinal imaging

  • December 9, 2025

  • 5 min
Inside the Aging Eye

A comprehensive new Elsevier publication brings global expertise together to unpack how aging drives ocular structure, function, and disease

  • April 28, 2026

  • 2 min
Evaluation of Laser Doppler Holography for Assessing Choroidal Blood Flow: A Comprehensive Review of Technical Features, Validation Research, and Clinical Uses